Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Predoctoral Training Program in Human Genetics, Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Curr Psychiatry Rep. 2020 Apr 21;22(5):24. doi: 10.1007/s11920-020-01148-1.
We review the ways in which stem cells are used in psychiatric disease research, including the related advances in gene editing and directed cell differentiation.
The recent development of induced pluripotent stem cell (iPSC) technologies has created new possibilities for the study of psychiatric disease. iPSCs can be derived from patients or controls and differentiated to an array of neuronal and non-neuronal cell types. Their genomes can be edited as desired, and they can be assessed for a variety of phenotypes. This makes them especially interesting for studying genetic variation, which is particularly useful today now that our knowledge on the genetics of psychiatric disease is quickly expanding. The recent advances in cell engineering have led to powerful new methods for studying psychiatric illness including schizophrenia, bipolar disorder, and autism. There is a wide array of possible applications as illustrated by the many examples from the literature, most of which are cited here.
我们综述了干细胞在精神疾病研究中的应用方式,包括基因编辑和定向细胞分化方面的相关进展。
诱导多能干细胞(iPSC)技术的最新发展为精神疾病的研究创造了新的可能。iPSC 可以从患者或对照中获得,并分化为多种神经元和非神经元细胞类型。可以根据需要编辑它们的基因组,并评估它们的多种表型。这使得它们特别适合研究遗传变异,这在我们对精神疾病遗传学的认识迅速扩展的今天尤为有用。细胞工程的最新进展为研究精神疾病(包括精神分裂症、双相情感障碍和自闭症)提供了强大的新方法。文献中有许多例子说明了广泛的可能应用,这里引用了其中的大部分。